These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9013214)

  • 1. Caerulein may potentiate morphine-induced antinociception by cholecystokinin-A and/or cholecystokinin-B receptor mechanisms.
    Rezayat M; Oreizi S; Zarrindast MR
    Gen Pharmacol; 1997 Feb; 28(2):337-40. PubMed ID: 9013214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of caerulein and CCK antagonists on tolerance induced to morphine antinociception in mice.
    Zarrindast MR; Zabihi A; Rezayat M; Rakhshandeh H; Ghazi-Khansari M; Hosseini R
    Pharmacol Biochem Behav; 1997 Sep; 58(1):173-8. PubMed ID: 9264087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin receptor mechanism(s) and morphine tolerance in mice.
    Zarrindast MR; Nikfar S; Rezayat M
    Pharmacol Toxicol; 1999 Jan; 84(1):46-50. PubMed ID: 9974190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cholecystokinin receptors in induction of antinociception in hot-plate test.
    Rezayat M; Rahnavard A; Zarrindast MR
    Pharmacol Toxicol; 2000 Aug; 87(2):58-62. PubMed ID: 10989941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel CCK antagonist L364,718 abolished caerulein- but potentiates morphine-induced antinociception.
    Rattray M; Jordan CC; De Belleroche J
    Eur J Pharmacol; 1988 Jul; 152(1-2):163-6. PubMed ID: 3208830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between antinociception induced by cholecystokinin antagonists and GABA agonists in the tail-flick test.
    Zarrindast MR; Rezayat M; Ghanipoor N; Parvini S
    Pharmacol Toxicol; 1998 Oct; 83(4):143-8. PubMed ID: 9820874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive effect of intracerebroventricular administration of cholecystokinin antagonist in nerve-ligated mice.
    Zarrindast MR; Samiee F; Rezayat M
    Pharmacol Toxicol; 2000 Oct; 87(4):169-73. PubMed ID: 11097270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.
    Vasar E; Harro J; Lang A; Pôld A; Soosaar A
    Psychopharmacology (Berl); 1991; 105(3):393-9. PubMed ID: 1798834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
    Vasar E; Stephenson JD; Meldrum BS
    Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caerulein changes morphine-induced antinociception depending on pretreatment times.
    Zarrindast MR; Rezayat M
    Gen Pharmacol; 1994 Mar; 25(2):311-6. PubMed ID: 8026731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats.
    Lu L; Huang M; Liu Z; Ma L
    Neuroreport; 2000 Mar; 11(4):829-32. PubMed ID: 10757528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cholecystokinin receptor agonist and antagonists on morphine dependence in mice.
    Zarrindast MR; Malekzadeh A; Rezayat M; Ghazi-Khansari M
    Pharmacol Toxicol; 1995 Dec; 77(6):360-4. PubMed ID: 8835359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment.
    Lavigne GJ; Millington WR; Mueller GP
    Neuropeptides; 1992 Feb; 21(2):119-29. PubMed ID: 1557183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats.
    Männistö PT; Lang A; Harro J; Peuranen E; Bradwejn J; Vasar E
    Naunyn Schmiedebergs Arch Pharmacol; 1994 May; 349(5):478-84. PubMed ID: 8065461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of cholecystokinin-A receptors in regulation of thyrotropin (TSH) secretion in male rats.
    Männistö PT; Peuranen E; Harro J; Vasar E
    Neuropeptides; 1992 Dec; 23(4):251-8. PubMed ID: 1475033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the peptidase inhibitor RB 101 and a CCK-B antagonist strongly enhances antinociceptive responses.
    Maldonado R; Derrien M; Noble F; Roques BP
    Neuroreport; 1993 Jul; 4(7):947-50. PubMed ID: 8369487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-740,093, a new antagonist of the CCK-B receptor, potentiates the antinociceptive effect of morphine: electrophysiological and behavioural studies.
    Xu XJ; Hoffmann O; Wiesenfeld-Hallin Z
    Neuropeptides; 1996 Apr; 30(2):203-6. PubMed ID: 8771563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for cholecystokininA receptors in bovine adrenal chromaffin cells.
    Aarnisalo AM; Vainio PJ; Männistö PT; Vasar E; Tuominen RK
    Neuroreport; 1996 Sep; 7(13):2167-70. PubMed ID: 8930982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
    Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat.
    Friedrich AE; Gebhart GF
    J Pharmacol Exp Ther; 2000 Feb; 292(2):538-44. PubMed ID: 10640290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.